TruStem Cell Therapy™ for IBD
Anemia
Abdominal pain
Vomiting
Diarrhea
Rectal bleeding
Severe cramps/muscle spasms in the pelvic region
What is Inflammatory Bowel Disease?
Inflammatory bowel disease (IBD) is a chronic autoimmune condition that principally consists of two types of illnesses, Crohn’s disease and ulcerative colitis. These conditions are caused by the body’s own immune system attacking components of the digestive track, also known as the gastrointestinal (GI) track. Those with Crohn’s disease may incur damage at any location along the GI track including the mouth, esophagus, stomach, small intestine, colon, and/or anus. Further, damage can occur within any layer of tissue in the GI track. Alternatively, damage noted in ulcerative colitis occurs primarily in the colon and rectum, and only at the inner most layer of tissue (called the mucosa). Though rarely fatal, IBD may severely reduce an individual’s quality of life.
There are two types of Inflammatory Bowel Disease:
Crohn’s Disease
is a chronic inflammatory bowel disease that affects the lining of the digestive tract.
Ulcerative Colitis
is a chronic, inflammatory bowel disease that causes inflammation in the digestive tract.
What Causes Inflammatory Bowel Disease?
The exact cause of inflammatory bowel disease remains unknown. Previously, diet and stress were suspected, but now doctors know that these factors may aggravate but don’t cause IBD.
One possible cause is an immune system malfunction. When your immune system tries to fight off an invading virus or bacterium, an abnormal immune response causes the immune system to attack the cells in the digestive tract, too.
What type of stem cells are used and why?
TruStem Cell Therapy provides access to treatment that utilizes a patient’s stem cells isolated from their own bone marrow. There are multiple inherent benefits afforded by the utilization of bone marrow derived stem cells as Bone marrow (BM) and bone marrow components function in various diverse, innate therapeutic capacities.
Hematopoietic stem cells (HSCs), found within BM, are the body’s source of most cells found in the peripheral or circulating blood. These include red blood cells and white blood cells (such as monocytes). In addition to HSCs, mesenchymal stem cells (MSCs) are also contained within BM. Evidence suggests MSCs can enter the circulating blood during injury and have been shown to readily home to areas of injury or inflammation. Once at these damaged tissue sites, MSCs can exert both protective cellular and immunomodulatory effects believed to be critical in many neurological and auto-immune conditions.
What steps are involved in receiving treatment through TruStem Cell Therapy?
Harvest
First a blood draw is performed followed by a minimally invasive bone marrow harvest via the iliac crest. Approximately 100cc’s of a patient’s own bone marrow is harvested through a minimally invasive, bone marrow aspiration procedure. TruStem Cell Therapy utilizes a powered bone marrow access system combined with local anesthetic allowing for consistently larger specimen of cells, extremely low levels of pain/invasiveness reported by most patients, and higher levels of sterility.
Bone marrow aspirate is preferentially utilized because it is one of the richest, most accessible sources of stem cells in the human body and falls within the FDA guidelines of minimal manipulation.
Process + Activate
Both the blood and bone marrow are immediately delivered to our dedicated, onsite laboratory staffed by our team of technicians. Once your sample is in the lab our advanced proprietary process isolates and excites regenerative cells and concentrates healing factors to hyper-physiological levels in order to facilitate the creation of a highly effective, injectable therapeutic.
Stem cell activation is part of what makes TruStem Cell Therapy unique. The activation procedure is designed to augment efficacy.
Administer
TruStem Cell Therapy utilizes both systematic and novel administration methods to fully saturate the body with stem cells while targeting specific areas of injury.
How are stem cells administered back into IBD patients through TruStem Cell Therapy?
Inflammatory Bowel Disease patients who receive stem cell therapy through us can receive a systemic administration of their stem cells:
Systemic IV infusion of their stem cells to fully saturate the entire body.
What is unique about receiving stem cell therapy through TruStem Cell Therapy for IBD?
Our focus is safety, efficacy, and patient-centric care when providing access to superior stem cell therapy.
We utilize only board certified surgeons, physicians and accredited clinicians to provide care for patients.
Laboratory protocols are developed and refined by our PhD Neuroscientist.
A clinical team with expertise in practicing cellular based medicine.
Accredited Surgical Centers for enhanced procedural and patient safety
Targeted administration methods that direct stem cells toward specific
Skilled Patient Advocates who are trained to provide truthful, realistic expectations resulting from stem cell therapy. We do not make outlandish promises of cures or inaccurate claims related to improvement rates.
Can this treatment cure IBD?
It is important for patients and caregivers to understand that current therapies, including stem cell treatment, do not provide a cure for IBD. However, TruStem cell therapy does have the potential to improve a patient’s quality of life by reducing symptoms and complications related to IBD as well as slowing its progression.
